Power Law company profile

Vapotherm

Biotech & Life Sciences · Exeter, United States · Founded 1999 · IPO 2018 Thoroughbred

Develops and manufactures innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders

Valuation

$133M

Market cap · 2026

Revenue

$69M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

11 investors on Vapotherm's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 11 investors entered at this stage

Arnerich Massena

Kaiser Permanente Ventures

Crestline Investors

GE Asset Management

Redmile Group

Perceptive Advisors

SightLine Partners

Integral Capital Partners

Adage Capital

Gilde Healthcare

QuestMark Partners

Global footprint

Where Vapotherm has talent and traffic

Workforce by country

14 countries with
team presence

🇺🇸 United States73.7%

🇲🇽 Mexico12.2%

🇸🇬 Singapore4.1%

🇬🇧 United Kingdom3.6%

🇩🇪 Germany1.7%

Top 5 of 14 shown

Web traffic by country

9K monthly visits
across markets

🇺🇸 United States67.8%

🇮🇱 Israel17.8%

🇮🇳 India10%

🇧🇷 Brazil5.6%

Top 4 markets shown

Market sentiment

What the market is saying about Vapotherm

An AI-synthesized read of the highest-engagement posts about Vapotherm on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vapotherm on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles